Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Cancer Chemotherapy and Pharmacology
|
August 13, 2002
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer
D K Park, C W Ryan, M E Dolan, et al.
The Journal of Organic Chemistry
|
January 26, 1996
Synthesis of trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonists: Application of the Cis-Thermal Elimination of Carbonates to Alkaloid Synthesis
John A. Werner, Louis R. Cerbone, Scott A. Frank, et al.
The Journal of Organic Chemistry
|
June 24, 1977
Cannabinoids. 3. Synthetic approaches to 9-ketocannabinoids. Total synthesis of nabilone
R A Archer, W B Blanchard, W A Day, et al.
Journal of Medicinal Chemistry
|
February 1, 1971
Chemistry of cephalosporin antibiotics. 22. Chemistry and biological activity of 3-alkoxymethyl cephalosporins
J A Webber, G W Huffman, R E Koehler, et al.
Investigational New Drugs
|
June 17, 2000
CI-980 in advanced melanoma and hormone refractory prostate cancer
C W Ryan, K L Shulman, J M Richards, et al.
The Journal of Organic Chemistry
|
May 7, 1971
Chemistry of cephalosporin antibiotics. XXI. Conversion of penicillins to cephalexin
R R Chauvette, P A Pennington, C W Ryan, et al.
Zoonoses and Public Health
|
February 17, 2018
Public health response to an imported case of canine melioidosis
C W Ryan, K Bishop, D D Blaney, et al.
Nature Communications
|
September 10, 2024
RING1 missense variants reveal sensitivity of DNA damage repair to H2A monoubiquitination dosage during neurogenesis
C W Ryan, S L Regan, E F Mills, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2026
DART (NCI/SWOG S1609): Comprehensive Final Results from Dual Checkpoint Inhibition with CTLA-4 and PD-1 Blockade in Rare Cancers
S P Patel, M Othus, Y K Chae, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 12, 2025
A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors
S P Chawla, E Abella, S Wieland, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Cancer Chemotherapy and Pharmacology
|
August 13, 2002
A phase II trial of oral temozolomide in patients with metastatic renal cell cancer
D K Park, C W Ryan, M E Dolan, et al.
The Journal of Organic Chemistry
|
January 26, 1996
Synthesis of trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonists: Application of the Cis-Thermal Elimination of Carbonates to Alkaloid Synthesis
John A. Werner, Louis R. Cerbone, Scott A. Frank, et al.
The Journal of Organic Chemistry
|
June 24, 1977
Cannabinoids. 3. Synthetic approaches to 9-ketocannabinoids. Total synthesis of nabilone
R A Archer, W B Blanchard, W A Day, et al.
Journal of Medicinal Chemistry
|
February 1, 1971
Chemistry of cephalosporin antibiotics. 22. Chemistry and biological activity of 3-alkoxymethyl cephalosporins
J A Webber, G W Huffman, R E Koehler, et al.
Investigational New Drugs
|
June 17, 2000
CI-980 in advanced melanoma and hormone refractory prostate cancer
C W Ryan, K L Shulman, J M Richards, et al.
The Journal of Organic Chemistry
|
May 7, 1971
Chemistry of cephalosporin antibiotics. XXI. Conversion of penicillins to cephalexin
R R Chauvette, P A Pennington, C W Ryan, et al.
Zoonoses and Public Health
|
February 17, 2018
Public health response to an imported case of canine melioidosis
C W Ryan, K Bishop, D D Blaney, et al.
Nature Communications
|
September 10, 2024
RING1 missense variants reveal sensitivity of DNA damage repair to H2A monoubiquitination dosage during neurogenesis
C W Ryan, S L Regan, E F Mills, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2026
DART (NCI/SWOG S1609): Comprehensive Final Results from Dual Checkpoint Inhibition with CTLA-4 and PD-1 Blockade in Rare Cancers
S P Patel, M Othus, Y K Chae, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 12, 2025
A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors
S P Chawla, E Abella, S Wieland, et al.
Page
of 3